Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 14, 2026; 32(34): 119605
Published online Sep 14, 2026. doi: 10.3748/wjg.119605
Published online Sep 14, 2026. doi: 10.3748/wjg.119605
Figure 1 Administration of Cladosporium cladosporioides attenuated visceral hypersensitivity and gut motility in trinitrobenzene sulfonic acid-treated mice.
A: Schematic diagram showing the timeline of model establishment, Cladosporium cladosporioides gavage, sample collection and behavioral observation; B: Visceral hypersensitivity in mice evaluated by CRD-AWR at 20, 40, 60, and 80 mmHg. Tow-way ANOVA; C: Fecal weight, frequency, and water content; D: Representative images of hematoxylin and eosin-stained tissues (n = 7). Scale bar = 100 μm. aP < 0.05, bP < 0.01, cP < 0.001. TNBS: Trinitrobenzene sulfonic acid.
- Citation: Guo CL, Zhang SQ, Zheng HN, Chi Y, Wang HH. Cladosporium cladosporioides ameliorates visceral hypersensitivity in irritable bowel syndrome-like mice by inhibiting dectin-1 signaling and mast cell activation. World J Gastroenterol 2026; 32(34): 119605
- URL: https://www.wjgnet.com/1007-9327/full/v32/i34/119605.htm
- DOI: https://dx.doi.org/10.3748/wjg.119605